TR200002809T2 - Sert, çabuk eriyen setirizin formülasyonları. - Google Patents

Sert, çabuk eriyen setirizin formülasyonları.

Info

Publication number
TR200002809T2
TR200002809T2 TR2000/02809T TR200002809T TR200002809T2 TR 200002809 T2 TR200002809 T2 TR 200002809T2 TR 2000/02809 T TR2000/02809 T TR 2000/02809T TR 200002809 T TR200002809 T TR 200002809T TR 200002809 T2 TR200002809 T2 TR 200002809T2
Authority
TR
Turkey
Prior art keywords
hard
melting
cetirizine
fast
alkaline earth
Prior art date
Application number
TR2000/02809T
Other languages
English (en)
Inventor
Tritthart Wolfram
Andre Piskernig Mario
Original Assignee
Asta Medica Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Aktiengesellschaft filed Critical Asta Medica Aktiengesellschaft
Publication of TR200002809T2 publication Critical patent/TR200002809T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

Bulus setirizin veya setirizinin farmasötik olarak tahammül edilir tuzlarini, en az bir adet yenebilen organik asittten ve/veya bunlarin tuzlarindan, alkali ve/veya toprak alkalikarbonatlarindan veya toprak alkalihidrojenkarbonatlarindan olusan bir efervesan temel maddesini ve muhtemelen farmasötik açidan kabul edilebilir yardimci maddeleri içeren, agizdan alinan, sert, çabuk eriyen efervesan formülasyonlari ile ilgilidir.
TR2000/02809T 1998-03-31 1999-03-20 Sert, çabuk eriyen setirizin formülasyonları. TR200002809T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19814256A DE19814256A1 (de) 1998-03-31 1998-03-31 Feste, schnellzerfallende Cetirizin-Formulierungen

Publications (1)

Publication Number Publication Date
TR200002809T2 true TR200002809T2 (tr) 2000-12-21

Family

ID=7863014

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/02809T TR200002809T2 (tr) 1998-03-31 1999-03-20 Sert, çabuk eriyen setirizin formülasyonları.

Country Status (31)

Country Link
US (1) US6245353B1 (tr)
EP (1) EP1067904B1 (tr)
JP (1) JP2002509873A (tr)
KR (1) KR100653568B1 (tr)
CN (1) CN1136838C (tr)
AR (1) AR018828A1 (tr)
AT (1) ATE209899T1 (tr)
AU (1) AU750140B2 (tr)
BG (1) BG64741B1 (tr)
BR (1) BR9909233A (tr)
CA (1) CA2326809C (tr)
CY (1) CY1107331T1 (tr)
CZ (1) CZ300704B6 (tr)
DE (2) DE19814256A1 (tr)
DK (1) DK1067904T3 (tr)
ES (1) ES2168013T3 (tr)
HK (1) HK1036217A1 (tr)
HU (1) HU227477B1 (tr)
IL (1) IL138606A (tr)
NO (1) NO329071B1 (tr)
NZ (1) NZ506988A (tr)
PL (1) PL191266B1 (tr)
PT (1) PT1067904E (tr)
RU (1) RU2216318C2 (tr)
SI (1) SI1067904T1 (tr)
SK (1) SK284476B6 (tr)
TR (1) TR200002809T2 (tr)
TW (1) TWI233808B (tr)
UA (1) UA57615C2 (tr)
WO (1) WO1999049843A1 (tr)
ZA (1) ZA200005134B (tr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0303700A3 (en) 2000-07-17 2006-07-28 Astellas Pharma Inc Chuo Ku Pharmaceutical composition improved in peroral absorbability
PL212123B1 (pl) * 2002-01-15 2012-08-31 Ucb Farchim Sa Doustna kompozycja farmaceutyczna
BR0308927A (pt) * 2002-04-04 2005-01-04 Pfizer Prod Inc Comprimido mastigável de sabor agradável
ES2624585T3 (es) * 2004-05-28 2017-07-17 Imaginot Pty Ltd. Sistema de suministro de compuesto terapéutico oral
US8216610B2 (en) 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
US8758816B2 (en) * 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
ES2704482T3 (es) 2004-11-24 2019-03-18 Meda Pharmaceuticals Inc Composiciones que comprenden azelastina y sus métodos de uso
US20070020330A1 (en) * 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
US20060198885A1 (en) * 2005-02-22 2006-09-07 Sun Pharmaceutical Industries Ltd. Oral pharmaceutical composition
AU2006317530B2 (en) 2005-11-28 2011-09-01 Imaginot Pty Ltd Oral therapeutic compound delivery system
WO2010028101A1 (en) * 2008-09-05 2010-03-11 Mcneil-Ppc, Inc. Method for making cetirizine tablets
PE20120647A1 (es) * 2009-03-13 2012-05-31 Nucitec Sa De Cv Composiciones y metodos para el tratamiento y prevencion de la enfermedad cardiovascular
WO2011146032A2 (en) * 2010-05-18 2011-11-24 Mahmut Bilgic Effervescent formulations
ES2541723T3 (es) 2012-06-12 2015-07-24 The Procter & Gamble Company Forma de dosificación efervescente
US20140371174A1 (en) 2013-06-12 2014-12-18 The Procter & Gamble Company Effervescent Dosage Form
JP5945191B2 (ja) * 2012-08-09 2016-07-05 株式会社ファンケル 口腔内速崩錠
JP6092672B2 (ja) * 2013-03-21 2017-03-08 株式会社ファンケル 口腔内速崩壊性錠剤
KR101591319B1 (ko) * 2013-12-03 2016-02-18 에프엔바이오 주식회사 홍삼 발포정의 제조방법
TW201605447A (zh) * 2014-06-20 2016-02-16 美林塔治療學有限公司 處理感染的方法
TWI705814B (zh) * 2014-06-20 2020-10-01 美商梅琳塔有限責任公司 醫藥組成物及其用途
EP3061501A1 (en) 2015-02-27 2016-08-31 Rottapharm Ltd. Composition for the treatment of acne
EP3117825A1 (en) 2015-07-16 2017-01-18 Rottapharm S.p.A. Oral formulation comprising berberine and morus alba extract
CN106109422A (zh) * 2016-07-28 2016-11-16 北京万全德众医药生物技术有限公司 盐酸左西替利嗪泡腾颗粒及其制备方法
US10624921B2 (en) 2016-11-15 2020-04-21 Berkeley Nox Limited Dietary supplements
JP2018108950A (ja) * 2016-12-28 2018-07-12 沢井製薬株式会社 レボセチリジン塩酸塩含有口腔内崩壊錠
WO2019099003A2 (en) * 2017-11-15 2019-05-23 Berkeley Nox Limited Novel dietary supplements
PT3799864T (pt) 2019-10-02 2023-05-25 Intas Pharmaceuticals Ltd Composições farmacêuticas sólidas efervescentes essencialmente isentas de sódio

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO155805C (no) * 1981-02-06 1987-06-10 Ucb Sa Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(4-(difenylmethyl)-1-piperazinyl)-eddiksyrer og deres amider og ikke-toksiske salter.
US4678661A (en) * 1983-09-28 1987-07-07 Gerhard Gergely Effervescent composition and method of making same
US4792448A (en) * 1987-06-11 1988-12-20 Pfizer Inc. Generic zero order controlled drug delivery system
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer A device for the controlled release of pneumatic substances, including the active substance, surrounded by an asymmetric membrane
US5178878A (en) 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
DK0542926T3 (da) * 1990-08-07 1995-05-15 Pfizer Brug af grænsefladepolymeriserede membraner i frigivelsesanordninger
DK0584108T3 (da) * 1991-05-13 2000-10-09 Boots Co Plc Farmaceutisk præparat omfattende ibuprofensalt
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
JPH08502288A (ja) * 1992-10-09 1996-03-12 ザ、プロクター、エンド、ギャンブル、カンパニー 感昌症状を治療するための医薬組成物及び用法
GB9224021D0 (en) * 1992-11-16 1993-01-06 Boots Co Plc Effervescent compositions
FR2698788B1 (fr) * 1992-12-09 1995-03-03 Union Pharma Scient Appl Composition pharmaceutique effervescente contenant de l'ibuprofène et son procédé de préparation.
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
DE59400446D1 (de) * 1993-04-15 1996-08-29 Gergely Gerhard Brausesystem mit einem alkali- und/oder metallempfindlichen, pharmazeutischen Wirkstoff, und Verfahren zur Herstellung
WO1994025009A1 (en) * 1993-04-30 1994-11-10 The Procter & Gamble Company Coated pharmaceutical compositions
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions

Also Published As

Publication number Publication date
WO1999049843A1 (de) 1999-10-07
KR20010034718A (ko) 2001-04-25
UA57615C2 (uk) 2003-06-16
BR9909233A (pt) 2000-11-28
US6245353B1 (en) 2001-06-12
CZ20003481A3 (en) 2001-05-16
IL138606A (en) 2005-07-25
ES2168013T3 (es) 2002-05-16
CA2326809C (en) 2008-11-18
ZA200005134B (en) 2000-12-21
CA2326809A1 (en) 1999-10-07
AU750140B2 (en) 2002-07-11
IL138606A0 (en) 2001-10-31
DE19814256A1 (de) 1999-10-07
KR100653568B1 (ko) 2006-12-05
CY1107331T1 (el) 2012-12-19
HUP0102676A3 (en) 2002-12-28
EP1067904A1 (de) 2001-01-17
RU2216318C2 (ru) 2003-11-20
SK14312000A3 (sk) 2001-07-10
DE59900501D1 (de) 2002-01-17
BG104843A (en) 2001-07-31
ATE209899T1 (de) 2001-12-15
NZ506988A (en) 2002-05-31
HUP0102676A2 (hu) 2001-11-28
CZ300704B6 (cs) 2009-07-22
BG64741B1 (bg) 2006-02-28
NO20004722D0 (no) 2000-09-21
HU227477B1 (en) 2011-07-28
HK1036217A1 (en) 2001-12-28
AR018828A1 (es) 2001-12-12
CN1295464A (zh) 2001-05-16
SK284476B6 (sk) 2005-04-01
JP2002509873A (ja) 2002-04-02
PL191266B1 (pl) 2006-04-28
EP1067904B1 (de) 2001-12-05
NO329071B1 (no) 2010-08-16
CN1136838C (zh) 2004-02-04
PL343199A1 (en) 2001-07-30
SI1067904T1 (en) 2002-04-30
DK1067904T3 (da) 2002-04-02
TWI233808B (en) 2005-06-11
NO20004722L (no) 2000-09-21
PT1067904E (pt) 2002-05-31
AU3925399A (en) 1999-10-18

Similar Documents

Publication Publication Date Title
TR200002809T2 (tr) Sert, çabuk eriyen setirizin formülasyonları.
NO20004721L (no) Bruseformuleringer
WO2000041681A3 (de) ARZNEIFORMULIERUNGEN ENTHALTEND EIN OPIOID UND EINEN α-AGONISTEN
LU91076I2 (fr) Tulathromycin et ses sels pharmaceutiquement acceptables (draxxin).
ATE260646T1 (de) Schnell zerfallende orale dosierungsform
TR199802698T2 (tr) Valsartanin kati oral doz formlari.
CY1111698T1 (el) Συνδυασμος που περιλαμβανει εναν ανταγωνιστη υποδοχεα ατ1 και εναν ενισχυτη εκκρισης ινσουλινης ή εναν ευαισθητοποιητη ινσουλινης
ITFI930247A1 (it) Antagonisti delle tachichinine,procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche.
DE60027575D1 (de) Verwendung von Spinosad oder einer Zusammensetzung enthaltend spinosad
SE8902288L (sv) Farmaceutisk komposition
TR199902175T2 (tr) Parasetamol içeren yutma tableti.
DK1007006T3 (da) Formulering af cefadroxilmonohydrattablet
ATE369857T1 (de) Methode zur stabilisierung von benzimidazol- verbindungen
TR200200359T2 (tr) Cgrp Antagonist'lerinin ve cgrp-release (Gevşeme)-Engelleyici Menopoza Bağlı Deri Kızarıklıklarında Kullanılması
HUP0104647A2 (hu) Hatóanyagként tilidin-mezilátot tartalmazó, szabályozott hatóanyag-leadású gyógyszerkészítmény
WO2005007137A3 (de) Ambroxolhaltige tabletten
TR200000116T2 (tr) Anestetik bir bileşiğin berrak, enjekte edilebilen formülasyonu
TR200003156T2 (tr) Bir aktif içerik olarak izomalt içeren terapötik soğuk algınlığına karşı ajan.
IS2258B (is) Setin tríasóló-pýridasín afleiða, lyfjasamsetningar gerðar úr henni
AU1028402A (en) Stable oral formulation containing benzimidazole derivative
IT1249696B (it) Composizioni farmaceutiche contenenti derivati di furano e procedimento per prepararle.
BR9812385A (pt) Formulações parasiticidas
HUP0202324A2 (hu) Prukaloprid orális oldat
TR199701617T1 (tr) Çiftliklerde üretilen baliklarda görülen parazitlerle mücadelede kullanilacak bir ajan.
NO20005681D0 (no) Nye formuleringer som inneholder paroxetin